Lundin J - Search Results

1

Expression and prognostic value of transcription factor PROX1 in colorectal cancer.

Skog M, Bono P, Lundin M, Lundin J, Louhimo J, Linder N, Petrova TV, Andersson LC, Joensuu H, Alitalo K, Haglund CH. Skog M, et al. Among authors: lundin j, lundin m. Br J Cancer. 2011 Oct 25;105(9):1346-51. doi: 10.1038/bjc.2011.297. Epub 2011 Oct 4. Br J Cancer. 2011. PMID: 21970873 Free PMC article.

2

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.

Lundin J, Roberts PJ, Kuusela P, Haglund C. Lundin J, et al. Br J Cancer. 1994 Mar;69(3):515-9. doi: 10.1038/bjc.1994.93. Br J Cancer. 1994. PMID: 7510116 Free PMC article.

3

A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer.

Victorzon M, Haglund C, Lundin J, Roberts PJ. Victorzon M, et al. Among authors: lundin j. Eur J Surg Oncol. 1995 Aug;21(4):379-84. doi: 10.1016/s0748-7983(95)92450-7. Eur J Surg Oncol. 1995. PMID: 7664902

4

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.

Haglund C, Lundin J, Kuusela P, Roberts PJ. Haglund C, et al. Among authors: lundin j. Br J Cancer. 1994 Sep;70(3):487-92. doi: 10.1038/bjc.1994.332. Br J Cancer. 1994. PMID: 8080735 Free PMC article.

5

Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9.

Lundin J, Roberts PJ, Kuusela P, Haglund C. Lundin J, et al. Anticancer Res. 1995 Sep-Oct;15(5B):2181-6. Anticancer Res. 1995. PMID: 8572621

6

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer.

Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C. Lundin J, et al. Oncology. 1996 Mar-Apr;53(2):104-11. doi: 10.1159/000227545. Oncology. 1996. PMID: 8604235

7

Expression of p53 protein as a prognostic factor in patients with gastric cancer.

Victorzon M, Nordling S, Haglund C, Lundin J, Roberts PJ. Victorzon M, et al. Among authors: lundin j. Eur J Cancer. 1996 Feb;32A(2):215-20. doi: 10.1016/0959-8049(95)00547-1. Eur J Cancer. 1996. PMID: 8664030

8

Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.

Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C. Lundin J, et al. Anticancer Res. 1995 Nov-Dec;15(6B):2659-68. Anticancer Res. 1995. PMID: 8669843

9

Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.

Carpelan-Holmström M, Haglund C, Lundin J, Järvinen H, Roberts P. Carpelan-Holmström M, et al. Among authors: lundin j. Eur J Cancer. 1996 Jun;32A(7):1156-61. doi: 10.1016/0959-8049(96)00030-5. Eur J Cancer. 1996. PMID: 8758246

10

A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy--a multivariate analysis.

Victorzon M, Lundin J, Haglund C, Nordling S, Roberts PJ. Victorzon M, et al. Among authors: lundin j. Int J Cancer. 1996 Jul 17;67(2):190-3. doi: 10.1002/(SICI)1097-0215(19960717)67:2<190::AID-IJC7>3.0.CO;2-O. Int J Cancer. 1996. PMID: 8760586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters